Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor

Cabozantinib is known as an inhibitor of receptor tyrosine kinases mainly targeting AXL receptor tyrosine kinase (AXL), MET proto-oncogene-encoded receptor tyrosine kinase (MET), and vascular endothelial growth factor receptor 2. Growth arrest-specific 6 (GAS6) and hepatocyte growth factor (HGF), th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hara, Takahito, Kimura, Akiko, Miyazaki, Tohru, Tanaka, Hiroshi, Morimoto, Megumi, Nakai, Katsuhiko, Soeda, Junpei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005370/
https://www.ncbi.nlm.nih.gov/pubmed/32055714
http://dx.doi.org/10.1016/j.bbrep.2020.100726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005370/
https://www.ncbi.nlm.nih.gov/pubmed/32055714
http://dx.doi.org/10.1016/j.bbrep.2020.100726

Ejemplares similares